Announced
Completed
Synopsis
Legend Capital, an investment firm based in Beijing, led a $224m Series C funding round in GenScript ProBio, a pharmaceutical research and manufacturing service provider, with participation from HighLight Capital and Xiamen C&D. The capital raising will help build up manufacturing capacity, further research and development capabilities and opportunistically acquire assets to develop its Contract Development and Manufacturing Organization business GenScript Biotech said.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.